Katsuaki Maehara/X
Jan 29, 2025, 22:05
Katsuaki Maehara: Immunotherapy trials in resectable NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues, posted on X:
“Immunotherapy trials in resectable NSCLC.
Updated clinical data as of January, 2025.
KEYNOTE-671 – 4 year update.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 12, 2025, 05:08
May 12, 2025, 04:22
May 11, 2025, 22:51
May 11, 2025, 18:14
May 11, 2025, 18:05